Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Hisse Senetlerindeki Sıralama #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Hisse Fiyatı
$0.2219522
Son senkronizasyon: 2025-09-11
Piyasa Değeri
$1.10B
Değişim (1 gün)
0.04%
Değişim (1 yıl)
0.17%
Ülke
CN
Ticaret Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Hubei Biocause Pharmaceutical Co., Ltd. (000627) için kazanç
Sep 2024 itibarıyla kazanç TTM: $-246.31M
Hubei Biocause Pharmaceutical Co., Ltd. şirketinin en son finansal raporlarına göre, mevcut kazancı $-246.31M'dir. 2022 yılında şirket $32.59M kazanç elde etti, bu 2021 yılındaki $53.98M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Hubei Biocause Pharmaceutical Co., Ltd. için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $-246.31M -6.66%
2023 $-263.90M -909.84%
2022 $32.59M -39.64%
2021 $53.98M -75.67%
2020 $221.88M -57.48%
2019 $521.80M 36.14%
2018 $383.27M -8.47%
2017 $418.73M -15.31%
2016 $494.40M 859.98%
2015 $51.50M 192.79%
2014 $17.59M -182.99%
2013 $-21.20M -981.31%
2012 $2.40M -112.99%
2011 $-18.51M -493.30%
2010 $4.71M -45.74%
2009 $8.67M 709.23%
2008 $1.07M -93.04%
2007 $15.40M 107.42%
2006 $7.42M 610.69%
2005 $1.04M 72.62%
2004 $605.05K -110.58%
2003 $-5.72M -392.76%
2002 $1.95M -72.00%
2001 $6.97M 18.03%
2000 $5.91M 0.00%
Benzer şirketler veya rakipler için kazanç